HOME >> BIOLOGY >> NEWS
Research funded to test new breast cancer medicine

BLACKSBURG, Va., July 9, 2001 Virginia Tech researchers in human nutrition and dairy science are beginning animal trials to test a new compound against breast cancer, thanks to a grant from Virginias Commonwealth Health Research Board (CHRB).

Barbara Davis, an assistant professor in human nutrition, foods, and exercise, is the lead investigator in a research project that will test the novel Schiff base-forming drug, which is known to strengthen the immune system -- an important mechanism for fighting cancer. Research from Davis lab has shown that this drug can kill breast cancer cells growing outside the body, without the help of the immune system.

Davis has already reported that a molecule of similar structure, vitamin B6, is effective at killing breast cancer cells, but the drug she is now testing can safely be used in humans at higher doses than B6 and therefore may represent a better breast cancer treatment option.

In collaboration with Mike Akers, the Alphin Professor of Dairy Science at Virginia Tech, and Prakash Nagarkatti, a researcher at the Medical College of Virginia, Davis will treat breast cancer in two types of mice, those with normal and those with weakened immune systems.

These experiments will help determine the involvement of the immune system in the cancer-killing ability of this drug. More importantly, they will show whether it is effective in treating breast cancer in the body.

The project is especially significant to Virginians, because mortality from breast cancer in Virginia is higher than the national average, although the incidence of breast cancer is below the national average, said Davis.


'"/>

Contact: Jean Elliott
elliottj@vt.edu
540 -231-5915
Virginia Tech
9-Jul-2001


Page: 1

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
4. Researchers identify protein promoting vascular tumor growth
5. Researchers devise potent new tools to curb ivory poaching
6. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
7. Researchers ID chlorophyll-regulating gene
8. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
9. Research suggests new avenue for stopping, preventing colon cancer
10. Researchers develop fast track way to discover how cells are regulated
11. Research on carbohydrate metabolism receives historical recognition

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/15/2016)... , Dec. 15, 2016  There is much more ... or starting the engine. Continental will demonstrate the intelligence ... Las Vegas . Through the combination of the ... Entry) and biometric elements, the international technology company is ... personalization and authentication. "The integration of biometric ...
(Date:12/8/2016)... , Dec. 8, 2016  Singulex, Inc., the ... Counting technology, entered into a license and supply agreement ... science. The agreement provides Singulex access to Thermo Scientific ... Europe is used to diagnose systemic bacterial ... States to aid in assessing the risk ...
(Date:12/7/2016)... Dec. 7, 2016   Veridium , a ... appointment of new CEO James Stickland . ... decades of experience, has served in senior executive ... he specialized in expanding a pipeline of venture ... He most recently served as managing director of ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... PLAINVIEW, N.Y. , Jan. 18, 2017 ... pathology services, announces the formation of an Executive Committee ... 2017 and beyond. John Cucci , ... been promoted from Director of Business Development to ... in 2015, Mr. Cucci served in senior sales leadership ...
(Date:1/18/2017)... 18, 2017   Boston Biomedical , an industry ... target cancer stemness pathways, will feature data from two ... the 2017 ASCO Gastrointestinal Cancers Symposium, held from January ... Napabucasin is an orally-administered investigational agent designed ... Cancer stem cells (CSCs) possess the property of ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... Dr. Dante Leven successfully implanted SpineFrontier’s A-CIFT™ Solofuse-P™. The operation took place on ... Valley Stream, NY. The procedure was an anterior cervical discectomy and fusion on ...
(Date:1/18/2017)... ... ... from a new study are stating that if levels of the blood test called ... there is still remaining prostate cancer cells that are more likely to come back, spreading ... an indicator of whether a man’s prostate cancer is growing or not,” stated Dr. ...
Breaking Biology Technology:
Cached News: